Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
500

Summary

Conditions
  • Glioma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Melanoma
  • Sarcoma
Type
Observational
Design
Observational Model: Case-OnlyTime Perspective: Prospective

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. To perform standardized molecular analysis for patients at MD Anderson to assist in personalized cancer therapy. II. To determine the frequency of mutations and co-mutations and other alterations in cancer-related genes in different tumor types. III. To establish a database of...

PRIMARY OBJECTIVES: I. To perform standardized molecular analysis for patients at MD Anderson to assist in personalized cancer therapy. II. To determine the frequency of mutations and co-mutations and other alterations in cancer-related genes in different tumor types. III. To establish a database of somatic mutations, copy number alterations, gene fusion/translocation information and other biomarker alterations and clinical characteristics that can be used to select patients that may be eligible for new targeted therapy trials. SECONDARY OBJECTIVES: I. To determine enrollment to pathway-targeted therapy trials by cancer genotype and ribonucleic acid (RNA) and protein expression, and plan additional pathway-targeted therapy trials. II. To determine how somatic and germline mutations in cancer-related genes, other molecular alterations affect response to commonly used anti-tumor therapies and cancer outcomes. III. To determine genomic alterations detectable in plasma and their evolution with treatment. IV. To perform multiplex and non-multiplex protein and protein/RNA screening using different platforms such as immunohistochemistry (IHC), immunofluorescence, (IF) mass spectrometry (MS), and nanostring of slides or tissue microarrays. V. To determine feasibility of identifying actionable targets and rationale drug combinations based on gene expression profiling and systems biology. OUTLINE: Patients' previously collected tissue samples are analyzed. Patients may also undergo collection of blood, saliva or buccal samples for analysis. Patients' medical records are reviewed.

Tracking Information

NCT #
NCT01772771
Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Funda Meric-Bernstam M.D. Anderson Cancer Center